Ameliorative Potential ofTamarindus indicaon High Fat Diet Induced Nonalcoholic Fatty Liver Disease in Rats
Open Access
- 4 February 2014
- journal article
- research article
- Published by Wiley in The Scientific World Journal
- Vol. 2014, 1-10
Abstract
Nonalcoholic fatty liver disease (NAFLD), the prevalence of which is rising globally with current upsurge in obesity, is one of the most frequent causes of chronic liver diseases. The present study evaluated the ameliorative effect of extract ofTamarindus indicaseed coat (ETS) on high fat diet (HFD) induced NAFLD, after daily administration at 45, 90, and 180 mg/kg body weight dose levels for a period of 6 weeks, in albino Wistar rats. Treatment with ETS at all tested dose levels significantly attenuated the pathological alterations associated with HFD induced NAFLDviz. hepatomegaly, elevated hepatic lipid and lipid peroxides, serum alanine aminotransferase, and free fatty acid levels as well as micro-/macrohepatic steatosis. Moreover, extract treatment markedly reduced body weight and adiposity along with an improvement in insulin resistance index. The study findings, therefore suggested the therapeutic potential of ETS against NAFLD, acting in part through antiobesity, insulin sensitizing, and antioxidant mechanisms.Keywords
This publication has 29 references indexed in Scilit:
- An Experimental Approach for Selecting Appropriate Rodent Diets for Research Studies on Metabolic DisordersBioMed Research International, 2013
- Current Concepts and Management Approaches in Nonalcoholic Fatty Liver DiseaseThe Scientific World Journal, 2013
- Multidisciplinary Pharmacotherapeutic Options for Nonalcoholic Fatty Liver DiseaseInternational Journal of Hepatology, 2012
- Non-alcoholic steatohepatitis: an overview including treatments with herbals as alternative therapeuticsJournal of Applied Biomedicine, 2012
- Etiopathogenesis of Nonalcoholic Steatohepatitis: Role of Obesity, Insulin Resistance and Mechanisms of HepatotoxicityInternational Journal of Hepatology, 2012
- Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal modelEuropean Journal of Nutrition, 2012
- The Role of Metformin in the Management of NAFLDExperimental Diabetes Research, 2011
- Protective effect of whey proteins against nonalcoholic fatty liver in ratsLipids in Health and Disease, 2011
- Impact of Dietary Polyphenols on Carbohydrate MetabolismInternational Journal of Molecular Sciences, 2010
- A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat DietJournal of Clinical Biochemistry and Nutrition, 2010